OrbiMed Israel GP Ltd., 10% Owner at Novus Therapeutics, Inc. (NVUS), sold 103,200 shares at $21.60 ($2.2M) on 2020-12-02, disclosed to the SEC on 2020-12-04.
Open-market sale of $2.2M NVUS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PHGE | BUY | 2019-12-09 | $86K | — | Filing → |